AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -50.0% | 1,850 | -35.1% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 2,850 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 2,850 | +54.1% | 0.00% | – |
| Q1 2019 | $2,000 | -85.7% | 1,850 | -78.3% | 0.00% | – |
| Q4 2018 | $14,000 | -33.3% | 8,540 | +30.6% | 0.00% | – |
| Q3 2018 | $21,000 | +75.0% | 6,540 | +58.0% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 4,140 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | +140.0% | 4,140 | +123.8% | 0.00% | – |
| Q4 2017 | $5,000 | -28.6% | 1,850 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | +600.0% | 1,850 | +640.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 250 | +21.4% | 0.00% | – |
| Q1 2014 | $0 | – | 206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |